By TNT Bureau
Jan 7, 2016: Healthcare technology in India is going to be a $40 billion market within the year 2025. However, the founder of InnAccel, India?s 1st healthcare technology incubator, Siraj Dhanani said that this huge opportunity is being totally ignored.
He said that it is a market which is being sub-optimally served and also there are international models for health tech innovation that can be productively applied in India.
InnAccel and healthcare system: The possible contributions
The general health care system of India is weak, besieged, and breaking down. People who can afford high-class medical care at private hospitals and medical centers are eager to pay for it. What about the general public?
Dhanani is eager to reduce the overall medical cost by aiding engineers and capitalists to introduce reasonable healthcare devices.
When the cost of the devices will be low, the overall care cost will also get reduced, thus leading to treatment of a vast number of patients.
He said that the aim is to make the world?s first assortment of health check products that will be engineered, designed and priced for international budding markets.
Even though there are other programs as well as incubators that aspire medical capitalists of India, there are considerably limited resources for people who desire to assemble equipment?not services or IT companies.
InnAccel is all about medical technologies. Presently, the accelerator consists of 2 start-ups under its division. Dhanani, nonetheless, has some daring goals: By 2020, he intends to build 50 projects and by 2025, he desires to have assisted in giving rise to 25 new healthcare technologies.
He explained that they are in a lookout for capitalists who are passionate about solving a large medical issues and influencing a huge number of lives. However passion alone is not sufficient. Dhanani is concerned with backing those capitalists, who are not scared to go out in the field and investigate matters in the rural areas of India.
He said that they should be able to give commitment towards the work for a period of 5 years or even more. They should have the passion to submerge themselves in the medical environment, learning with humbleness the issues that actually exist.
Getting hold of such individuals has been quiet a troubling task.
InnAccel started in 2014 and in the same year it scanned over 50 projects and wide array of capitalists and ended up in selecting only 2 ideas. Dhanani said that majority of the teams they find are reluctant to dirty their hands, and they are operating on input for one or two healthcare professionals only which doesn?t fit with InnAccel.
Highlights of Sattva and Coeo
Sattva and Coeo labs are the two ideas that fit the move. However, both were looking at comprehensive troubles: Over 600,000 patients in India suffer from ventilator-associated pneumonia and there are around India. In both cases, these are issues can?t be ignored.
Nachiket Deval and Nitesh Kumar Jangir, originator of Coeo Labs, spent 2 months in ambulances and emergency rooms to study more about VAP. Initially, they learnt about its harshness when they viewed a full-grown man admitted to the ICU due to head injury following a traffic accident. He was laid on the ventilator for2 days, but he was predicted to get well after 5 days. Unluckily, in the process, he fell prey to pneumonia which ultimately resulted in his death.
Deval said that they were extremely taken aback by the incident and it was unacceptable for them to actually view an unnecessary death.
Both the originators said that India falls prey to more than half a million VAP cases each year out of which around 200,000 become deadly. They dug into the matter further, looking at what causes the situation and striving towards a solution that highlights oral hygiene and administers secretion.
It has been seen that majority of the patients in the ICU are not given a working gag reflex. Instead, the patients have secretions which get infected by bacteria that lead them in contracting pneumonia.
Deval and Jangir?s invention senses the secretion and throws them away. They are now planning to take their invention to medical centers for clinical trials. Once they are successful in receiving worldwide certification, they look forward to introducing it in the market by 2017.
Likewise, InnAccel?s other idea, Sattva, has finished a prototype that will experience testing in the major metro cities such as Bangalore, Pune, Mumbai and Delhi. The concluding product, after essential adjustments is all set to launch in 2017.
Sattva is focused on maternal health. India has about 30 million pregnancies each year. About one-third is soaring risk which means that they required to be checked closely during labor said the founders of Sattva, Sumedh Kaulgud and Vibhav Joshi. However, 50% of the deliveries take place outside of hospitals, under the concern of a field nurse.
Hence, they have come up with Sattva Fetal Lite, a moveable, lightweight device capable of taking an electrocardiogram of a fetus. Both ideas, nonetheless, say that building such types of prototypes can be an overwhelming and lengthy process.